Deutsches Herzzentrum Muenchen - Recruiting 18 years or older. - Randomized Trial of Stenting After Dilation With or Without Paclitaxel Eluting Balloon or Atherectomy in Patients With Symptomatic Peripheral Artery Disease.
University of British Columbia - Recruiting 16 years to 90 years. - Ultrasound Guided Sciatic Perineural Catheter vs Surgically Placed Sciatic Stump Catheter for Below Knee Amputations: Is There A Difference in Patient Outcomes.
Merck Sharp & Dohme Corp. - Recruiting 40 years or older. - Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess Cardiovascular Outcomes Following Treatment With Ertugliflozin (MK-8835/PF-04971729) in Subjects With Type 2 Diabetes Mellitus and Established Vascular Disease.
Arteriocyte, Inc. - Recruiting 18 years to 85 years. - Phase I, Non-Randomized, Feasibility Study for the Use of Bone Marrow Cell Concentrate Prepared Using the Magellan System for the Treatment of Critical Limb Ischemia.
Novartis - Recruiting 18 years or older. - A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-controlled Study to Evaluate the Effects of Intravenous Serelaxin Infusion on Micro- and Macrovascular Function in Patients With Coronary Artery Disease.
Ethicon, Inc. - Recruiting 18 years or older. - A Prospective, Single-Arm, Observational, Non-interventional Study for EVICEL T Fibrin Sealant (Human) When Used as an Adjunct to Haemostasis in Vascular Surgery.
Humacyte, Inc. - Recruiting 18 years to 75 years. - A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft for Use as a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease.
Humacyte, Inc. - Recruiting 18 years to 80 years. - A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease.
Bayer - Recruiting 18 years or older. - Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels.
Abbott Vascular - Recruiting 18 years or older. - Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use..
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. - Recruiting 18 years to 75 years. - Postmarketing Surveillance Registry to Monitor Everolimus-eluting Bioresorbable Vascular Scaffold Following Rotational Atherectomy for the Treatment of Complex Coronary Lesions - The ASSURE ROT Registry.
Deutsches Herzzentrum Muenchen - Recruiting 18 years or older. - Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction.
Medtronic Vascular - Recruiting 18 years or older. - Resolute Integrity US A Postapproval Study of the Medtronic ResoluteT Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm.
Yaffa Golan, Ltd. - Recruiting 18 years or older. - A Pilot Study to Assess the Use of the Magic Foot in the Improvement of Subjective and Objective Parameters in Subjects With Foot Symptoms as a Result of Diabetes or Peripheral Vascular Disease..
University of British Columbia - Recruiting 30 years or older. - Early Post-Operative Dysglycemia in Patients With and Without Diabetes Post-Infrainguinal Bypass Surgery and the Effectiveness of a Diabetes Action Team in the Management of Diabetes Post Infrainguinal Bypass Surgery on Glycemic Control, Length of Stay, and Infection Rates: A Pilot Study.
Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Subjects without diabetes will have their blood glucose levels monitored while in the hospital
A.O. Ospedale Papa Giovanni XXIII - Recruiting 18 years or older. - In-Vivo Vascular Response of Sirolimus-,Paclitaxel- and Zotarolimus-Eluting Stents in Long Lesions Requiring Overlapping. A Prospective, Randomized, Controlled Study Using Optical Coherence Tomography.
sirolimus drug eluting coronary stent CypherT (Cordis Corp, Johnson & Johnson Co); paclitaxel polymer drug eluting stent Taxus LibertT (Boston Scientific, Natick MS); zotarolimus drug eluting coronary stent EndeavorT (Medtronic, Santa Rosa, CA); Libert bare metal coronary stent LibertT BMS(Boston Scientific, Natick, MS)